Molecular characterization of clinically isolated Pseudomonas aeruginosa with varying resistance to ceftazidime-avibactam and ceftolozane-tazobactam collected as a part of the ATLAS global surveillance program from 2020 to 2021

IF 4.1 2区医学 Q2 MICROBIOLOGY

Antimicrobial Agents and Chemotherapy Pub Date : 2024-09-10 DOI:10.1128/aac.00670-24

H. LiA. OliverR. K. ShieldsS. KamatG. StoneM. Estabrook1IHMA, Schaumburg, Illinois, USA2Microbiology Service, Son Espases University Hospital, IdISBa, CIBERINFEC, Palma, Illes Balears, Spain3Department of Medicine, Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, USA4Pfizer, Mumbai, India5Pfizer, Groton, Connecticut, USABoudewijn L. de Jonge

引用次数: 0

Abstract

Antimicrobial Agents and Chemotherapy, Ahead of Print.

查看原文本刊更多论文

对头孢唑肟-阿维巴坦和头孢羟氨苄-他唑巴坦具有不同耐药性的临床分离铜绿假单胞菌的分子特征，作为 2020 年至 2021 年 ATLAS 全球监测计划的一部分进行收集

抗菌剂与化疗》，印刷版前。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Antimicrobial Agents and Chemotherapy 医学-微生物学

CiteScore

10.00

自引率

8.20%

发文量

762

审稿时长

3 months

期刊介绍： Antimicrobial Agents and Chemotherapy (AAC) features interdisciplinary studies that build our understanding of the underlying mechanisms and therapeutic applications of antimicrobial and antiparasitic agents and chemotherapy.